MEDICAMEN BIOTECH LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 ,inter alia, to consider and approve the standalone and consolidated unaudited financial results of the company for the quarter ended on Decmeber 31, 2024.

pdf

Medicamen Biotech Ltd.

22 Jan 2025, 03:07PM

333.20

2.81%

Company Update

MEDICAMEN BIOTECH LTD.-$ - 531146 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 75 (5) of SEBI (DP) Regulations, 2018

pdf

Medicamen Biotech Ltd.

04 Jan 2025

333.20

2.81%

Company Update

MEDICAMEN BIOTECH LTD.-$ - 531146 - Intimation Regarding Change Of Name Of Registrar And Share Transfer …

BSE India

Intimation regarding change of name of Registrar and Share Transfer Agent (RTA) of the Company

pdf

Medicamen Biotech Ltd.

31 Dec 2024

333.20

2.81%

SAST

MEDICAMEN BIOTECH LTD.-$ - 531146 - Closure of Trading Window

BSE India

Intimation of Clsoure of Trading Window for the Quarter ending on December 31, 2024

pdf

Medicamen Biotech Ltd.

06 Dec 2024

333.20

2.81%

Company Update

MEDICAMEN BIOTECH LTD.-$ - 531146 - Clarification On Price Movement

BSE India

Clarification on Price Movement

pdf

Medicamen Biotech Ltd.

06 Dec 2024

333.20

2.81%

Company Update

MEDICAMEN BIOTECH LTD.-$ - 531146 - Clarification sought from Medicamen Biotech Ltd

BSE India

The Exchange has sought clarification from Medicamen Biotech Ltd on December 6, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%